Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial
Leader in redosable gene therapy Krystal Biotech, Inc. (NASDAQ: KRYS) announced today the United States Food and Drug…
Advanced Chemotherapy Technologies Receives $4 Million NIH Grant to Pursue Pancreatic Cancer Treatment
Clinical-stage drug delivery company Advanced Chemotherapy Technologies (ACT) announced that the company has been awarded a Phase IIb…
Merck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial
Today Merck & Co. (NYSE: MRK) announced that Keytruda has failed the Phase 3 clinical trial KEYNOTE-412 evaluating…
Cel-Sci Announces Multikine Immunotherapy Significantly Improves Overall Survival Benefit for Cancer Head & Neck Patients in Phase 3 Trial
Data Shows Significant Overall Survival Benefit for Cancer Patients with Multikine Treatment Regimen Followed by Surgery & Radiotherapy…
ImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug
In breaking news, clinical-stage biotechnology company ImmunityBio, Inc. (NASDAQ: IBRX) has announced acceptance by the FDA review of…
11/19/21
BioTech Health X Ortho Clinical Diagnostics Overview & Q&A Michael S. Iskra, Executive Vice President of Commercial Excellence…
Repertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery & T Cell Receptors
The collaboration between Repertoire and Yale seeks to identify novel antigenic reactivity of T cells in patients with…
Inhibikase Therapeutics To Present Phase 1/1b Trial Results at AD/PD Alzheimer’s & Parkinson’s Diseases Conference
Clinical-stage pharmaceutical company Inhibikase Therapeutics, Inc. (Nasdaq: IKT) recently announced that President and CEO Dr. Milton Werner, Ph.D. will be…
Virios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results
In a shocking failure, Virios Therapeutics announced this morning pre-market that topline results from its FORTRESS (Fibromyalgia Outcome…
BioTech Health X CEO Series: Virios Therapeutics Greg Duncan
BioTech Health X works to deliver the latest coverage and updates in the biotechnology sector. This includes providing…
Stevanato Announces Proposed Initial Public Offering (IPO)
Stevanato, the Italian family-owned yet global manufacturer and provider of drug containment, drug delivery and diagnostic solutions, has…
Oracle Health Raises $2.7M from Investors, Turns Down Y Combinator Funding
Innovative medtech company Oracle Health has raised over $2.7 Million from investors through the Republic platform. The company…
Infinity Pharmaceuticals Add 2 New Members to Board of Directors
Clinical-stage biotech Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced the change of 2 new Board of Directors roles including…
CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022
CEL-SCI recently presented its Phase 3 data at ESMO 2022, which revealed that Neoadjuvant Multikine achieved groundbreaking tumor…
Capricor CEO to Present at American Society of Gene and Cell Therapy Annual Meeting Ahead of Q1 Earnings Update
May 13 is a busy day for biotechnology company Capricor Therapeutics (NASDAQ: CAPR). The company which focuses on…
COVID-19 Rocks Yankees, 8th Vaccinated Member to Test Positive – Virology Experts Weigh In
Professional Major League Baseball organization the New York Yankees have been rocked this week with COVID-19 after 8…
NTx Hires Bristol-Myers Squibb Veteran Biopharma Executive Nancy Rurkowski to Join its Board of Directors
The 35-year veteran of Bristol-Myers Squibb brings manufacturing operations and product launch leadership expertise to drive NTx commercialization…
Xontogeny CEO Chris Garabedian Exclusive Interview [September 2021]
As we expand our coverage of the biotechnology sector with the latest biotech news, our team at BioTech…